Insider Trading & Ownership of Andrew Gengos

Location
Bothell, WA
Summary
The estimated net worth of Andrew Gengos is at least $55,203 dollars as of 05 May 2026. Andrew Gengos is the CFO and Chief Business Officer of Athira Pharma, Inc. and owns shares of LeonaBio, Inc. (LONA) stock worth about $55.2K.
Signature
/s/ David Strauss, as Attorney-in-Fact for Andrew Gengos
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Andrew Gengos and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Andrew Gengos has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $55,203.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Athira Pharma, Inc. ($55,203).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Andrew Gengos

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LONA Athira Pharma, Inc. CFO and Chief Business Officer $55,203 03 Sep 2024
TERN Terns Pharmaceuticals, Inc. Chief Financial Officer $0 +$96,366 05 May 2026
CYT Cyteir Therapeutics, Inc. Chief Business Officer 22 Feb 2022
TTRX Global Health Solutions, Inc Director 08 Oct 2025

Insider Transactions Reported by Andrew Gengos:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .